Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Acutus Medical Reports First Quarter 2024 Financial Results
-
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
-
Curaleaf Reports First Quarter 2024 Results
-
Cambium Networks Reports First Quarter 2024 Financial Results
-
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress
-
Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
-
MARPAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
-
Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
-
WHITE MOUNTAINS REPORTS FIRST QUARTER RESULTS
-
Cutera Announces First Quarter 2024 Financial Results
-
Everbridge Announces First Quarter 2024 Financial Results
-
Audacy Reports First Quarter Results
-
University of Phoenix Hosts Educational Equity Webinar on Understanding AI's Influence on Accessibility and Inclusion
-
Ross Stores, Inc. Announces First Quarter 2024 Earnings Release and Conference Call
-
MindMed to Participate at May Investor Conferences
-
GAN Reports First Quarter 2024 Financial Results
-
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights
-
American Shared Hospital Services Announces Closing of Acquisition of 60% Majority Interest in Three Radiation Therapy Cancer Centers in Rhode Island
-
Quantum-Si Reports First Quarter 2024 Financial Results
-
Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
-
Franklin Resources, Inc. Announces Month-End Assets Under Management
-
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
-
Progyny, Inc. Announces First Quarter 2024 Results
-
Oxbridge Re Holdings Limited Reports First Quarter 2024 Results
-
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
-
Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
-
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
-
Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
-
CarGurus Announces First Quarter 2024 Results
-
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
-
First Quantum Minerals Announces Voting Results for the Election of Directors
-
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
-
Research Frontiers Reports First Quarter 2024 Financial Results and Will Host a Conference Call at 5:30p.m. Today
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
-
Collegium Announces CEO Transition
-
Athabasca Oil Corporation Announces Results from 2024 Annual Shareholder Meeting
-
AKAMAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
-
CleanSpark to Acquire 75 MW of Bitcoin Mining Sites in Wyoming for $18.75 Million
-
MYR Group Inc. to Attend Stifel Cross Sector Insight Investor Conference in June
-
American Licorice™ Pushes Flavor Boundaries with New Candy Lineup at Sweets & Snacks Expo 2024
-
Klappa, Lauber highlight exceptional year for WEC Energy Group
-
STRATTEC SECURITY CORPORATION Reports Fiscal 2024 Third Quarter Operating Results
-
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
-
Huntsman Announces Second Quarter 2024 Common Dividend


